Newsroom | 66259 results

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, l'un des principaux fournisseurs de solutions de séquençage monocellulaire accessibles et évolutives, annonce aujourd'hui le lancement d'Evercode™ Whole Blood Fixation, un nouveau kit qui permet la fixation immédiate du sang total directement au point de prélèvement. La technologie élimine le besoin d'isolement des PBMC sur site, d'équipement spécialisé ou de personnel qualifié, permettant aux équipes de recherche en hématologie translationnelle et p...

BEIJING--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), announced that its partner IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision oncology company, has received the clearance of an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for the initiation of a Phase 1 clinical trial of IDE034, a potential first-in-class B7H3/PTK7 bispecific antibody-drug conjugate (ADC). IDEAYA expects to begin patient enrollm...

WASHINGTON--(BUSINESS WIRE)--The Public Access to Sunscreens (PASS) Coalition commends Congress for passing the SAFE Sunscreen Standards Act (H.R. 3686/S. 2491) as part of the recent reauthorization of the Over-the-Counter Monograph User Fee Act (OMUFA) in H.R. 5371. This action represents a pivotal step toward modernizing sunscreen ingredient approvals and expanding access to safe and innovative cancer prevention tools. For years, outdated regulatory frameworks have restricted Americans’ acces...

RICHARDSON, Texas--(BUSINESS WIRE)--AdvoCare International, LLC, a leading health and wellness company, is thrilled to introduce Creatine+, a powerful new addition to its performance nutrition lineup. Formulated for athletes and active individuals, Creatine+ is designed to support muscle strength, recovery, endurance, and hydration—making it an essential tool for anyone serious about training. Each serving delivers 5 grams of unflavored creatine monohydrate, aligning with clinically researched...

ALL-REMOTE COMPANY/WILMINGTON, Del.--(BUSINESS WIRE)--Phreesia announces that Megan Turco, Director of Client Experience for Phreesia Network Solutions, has been named to MM+M’s 2025 40 Under 40 list....

WESTMINSTER, Colo.--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology company integrating novel delivery technology with standard of care therapies to transform treatment for patients with solid tumors, announced today that it will host a virtual key opinion leader (KOL) event on Monday, December 15, 2025 at 2:00 PM ET featuring Juan C. Camacho, MD (Florida State University), who will join company management to discuss the unmet need and cur...

WASHINGTON--(BUSINESS WIRE)--Dr. Krishnan Suthanthiran, President/Founder of TeamBest Global (TBG) companies and the International Society for Radiation Medicine & Molecular Imaging (ISRMMI), is urging closer collaboration with the Society of Nuclear Medicine and Molecular Imaging (SNMMI) to accelerate the adoption of theranostics and broaden treatment options for cancer patients worldwide. TBG has long been recognized for developing cost-effective, innovative technologies, and advanced the...

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired The Dunn Group (“TDG”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. TDG, headquartered in Totowa, NJ, is a competitive intelligence firm that focuses on providing primary business intelligence to clients in the pharmaceu...

ORLANDO, Fla.--(BUSINESS WIRE)--Outcomes® is formalizing the availability of Outcomes Insights, an advanced reporting platform that provides pharmacies with comprehensive visibility into their performance. Currently exclusive to Rx30 users, the solution equips teams with actionable intelligence to enhance operational efficiency and business health. “Outcomes Insights represents a major step forward in helping pharmacies unlock actionable intelligence,” said Jon Grice, VP, Pharmacy Insights for...

BOSTON--(BUSINESS WIRE)--Foundation Medicine Achieves Historic Milestone of 100 Approved Companion Diagnostic Indications, Solidifying Leadership in Precision Medicine...